Related Experiment Video
Updated: Oct 29, 2025

06:46
Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery
Published on: September 27, 2024
453
Clinical Statistical Analysis with Comparison between Pelvic and Non-pelvic Chondrosarcoma
Sayed Abdulla Jami1, Shi Jiandang1, Brotendu Shekhar Roy2
1Department of Spinal Surgery, General Hospital of Ningxia Medical University, Ningxia, People's Republic of China.
Oman Medical Journal
|July 9, 2021
Summary
Pelvic chondrosarcoma shows higher recurrence and amputation rates than other sites, despite similar overall survival. Early recurrence after surgery indicates a poor prognosis for these rare bone tumors.
Area of Science:
- Orthopedic Oncology
- Bone Tumors
- Surgical Pathology
Background:
- Chondrosarcomas are rare bone tumors with variable characteristics and controversial treatment approaches.
- Pelvic chondrosarcomas present unique diagnostic and therapeutic challenges.
Purpose of the Study:
- To analyze clinical statistics and prognostic factors of pelvic chondrosarcoma.
- To provide a reference for the clinical diagnosis and treatment of pelvic chondrosarcoma.
Main Methods:
- Retrospective analysis of 73 chondrosarcoma cases (2008-2017), with 24 pelvic and 49 non-pelvic cases.
- Comparison of clinical characteristics and prognostic factors between pelvic and non-pelvic chondrosarcoma groups.
- Statistical analysis using various methods to determine significance.
Main Results:
- Pelvic chondrosarcoma patients (n=24) had a median age of 43.5 years, with a male-to-female ratio of 1.4:1.
- Local recurrence rate was significantly higher in pelvic chondrosarcoma (83.3%) compared to other sites (34.7%) (p < 0.001).
- Amputation rate was also significantly higher for pelvic cases (50.0%) versus others (20.4%) (p = 0.010), though overall survival rates were not significantly different between groups.
Conclusions:
- Pelvic chondrosarcoma exhibits a higher local recurrence rate and increased likelihood of amputation compared to chondrosarcomas at other sites.
- Optimal diagnosis and treatment by experienced specialists are crucial for favorable outcomes in bone chondrosarcoma.
- Early local recurrence following surgical intervention is indicative of a poorer prognosis in pelvic chondrosarcoma cases.
Related Concept Videos
Comparing the Survival Analysis of Two or More Groups
361
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
361
Cancer Survival Analysis
484
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
484

